BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18192846)

  • 1. Combination of exercise and losartan enhances renoprotective and peripheral effects in spontaneously type 2 diabetes mellitus rats with nephropathy.
    Tufescu A; Kanazawa M; Ishida A; Lu H; Sasaki Y; Ootaka T; Sato T; Kohzuki M
    J Hypertens; 2008 Feb; 26(2):312-21. PubMed ID: 18192846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
    Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
    Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
    J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renoprotective and antihypertensive effect of combination therapy with a low protein diet, long-term exercise and angiotensin II receptor antagonist in rats with renal ablation].
    Sasaki Y; Kanazawa M; Ito O; Kohzuki M
    Nihon Jinzo Gakkai Shi; 2006; 48(1):4-13. PubMed ID: 16480061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A renoprotective effect of low dose losartan in patients with type 2 diabetes.
    Sawaki H; Terasaki J; Fujita A; Nakagawa S; Kanatsuna N; Sadahiro K; Isotani H; Imagawa A; Hanafusa T
    Diabetes Res Clin Pract; 2008 Jan; 79(1):86-90. PubMed ID: 17889959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus downregulates expression of connexin43 in rat aortic medial smooth muscle cells and can be reversed by simvastatin and losartan therapy.
    Sheu JJ; Tsai TH; Chang LT; Chiang CH; Youssef AA; Sun CK; Chang NK; Yip HK
    Chang Gung Med J; 2008; 31(2):136-44. PubMed ID: 18567413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
    Boor P; Celec P; Behuliak M; Grancic P; Kebis A; Kukan M; Pronayová N; Liptaj T; Ostendorf T; Sebeková K
    Metabolism; 2009 Nov; 58(11):1669-77. PubMed ID: 19608208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
    Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
    J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
    Choi SM; Seo MJ; Kang KK; Kim JH; Ahn BO; Yoo M
    Arch Pharm Res; 2009 Mar; 32(3):353-8. PubMed ID: 19387578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of losartan on glomerular sclerosis in rats with diabetic nephropathy].
    Xu JY; Tao LJ; Wang L; Ning WB; Liu JS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):836-40. PubMed ID: 18812664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of losartan on MT3-MMP and TIMP2 mRNA expressions in diabetic rat kidney].
    Wan X; Huang HH; Li JG
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1391-4. PubMed ID: 15604066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan.
    Mihailovic-Stanojevic N; Jovovic D; Miloradovic Z; Grujic-Milanovic J; Jerkic M; Markovic-Lipkovski J
    Nephrol Dial Transplant; 2009 Apr; 24(4):1142-50. PubMed ID: 18987260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
    Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
    Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat model.
    Tominaga N; Robert A; Izuhara Y; Ohtomo S; Dan T; Chihara K; Kurokawa K; Van Ypersele de Strihou C; Miyata T
    Nephrology (Carlton); 2009 Sep; 14(6):581-7. PubMed ID: 19712258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional hemodynamic effects of neutral endopeptidase inhibition and angiotensin (AT(1)) receptor antagonism alone or in combination in conscious spontaneously hypertensive rats.
    Gardiner SM; March JE; Kemp PA; Ballard SA; Bennett T
    J Pharmacol Exp Ther; 2006 Oct; 319(1):340-8. PubMed ID: 16825530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained tubulo-interstitial protection in SHRs by transient losartan treatment: an effect of decelerated aging?
    Baumann M; Bartholome R; Peutz-Kootstra CJ; Smits JF; Struijker-Boudier HA
    Am J Hypertens; 2008 Feb; 21(2):177-82. PubMed ID: 18188163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced effect of combined treatment with SMP-534 (antifibrotic agent) and losartan in diabetic nephropathy.
    Sugaru E; Nakagawa T; Ono-Kishino M; Nagamine J; Tokunaga T; Kitoh M; Hume WE; Nagata R; Taiji M
    Am J Nephrol; 2006; 26(1):50-8. PubMed ID: 16508247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central AT(1) receptor blockade increases metabolic cost during exercise reducing mechanical efficiency and running performance in rats.
    Leite LH; Lacerda AC; Balthazar CH; Marubayashi U; Coimbra CC
    Neuropeptides; 2007 Jun; 41(3):189-94. PubMed ID: 17350681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.